Home / Business and Economy / Bernstein Trims Texas Instruments' Price Target Amid Cautious Outlook

Bernstein Trims Texas Instruments' Price Target Amid Cautious Outlook

Summary

  • Bernstein cuts Texas Instruments' price target to $160 from $180
  • Semiconductor market recovery pace "disappointing," but turnaround underway
  • Texas Instruments' 2026 revenue and margin targets questioned
Bernstein Trims Texas Instruments' Price Target Amid Cautious Outlook

In a recent development, Texas Instruments Incorporated (NASDAQ:TXN), a leading semiconductor company, has encountered some obstacles in its recovery efforts. On October 22, 2025, the Bernstein SocGen Group trimmed the price target on Texas Instruments' stock from $180.00 to $160.00, while reaffirming its 'Market Perform' rating.

The research firm expressed concerns about the company's pace of recovery, describing it as "disappointing." However, Bernstein acknowledged that a turnaround is indeed underway. The firm also raised questions regarding Texas Instruments' 2026 scenario targets for both revenue and margins, highlighting the company's management credibility challenges.

During the earnings call on October 21, 2025, the management of Texas Instruments Incorporated (NASDAQ:TXN) appeared somewhat cautious, admitting that the semiconductor market recovery is continuing at a slower pace than expected. Haviv Ilan, the CEO, emphasized that customer inventories remain at low levels and their inventory depletion appears to be behind them. He also stated that the company is well-positioned with capacity and inventory, and has the flexibility to support a range of scenarios.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
According to the article, the semiconductor market recovery is continuing at a slower pace than expected, with customer inventories remaining at low levels.
The research firm has trimmed Texas Instruments' price target from $180.00 to $160.00, while reaffirming its 'Market Perform' rating on the stock. Bernstein cited a "disappointing" pace of recovery and raised questions about the company's 2026 revenue and margin targets.
Ilan stated that Texas Instruments is well-positioned with capacity and inventory, and has the flexibility to support a range of scenarios as the semiconductor market recovery continues.

Read more news on